EE197 EFFICACY AND ECONOMIC IMPACT OF METFORMIN PLUS GLIBENCLAMIDE TREATMENT DURING THE COVID-19 PANDEMIC IN ECUADORIAN OUTPATIENTS WITH TYPE II DIABETES MELLITUS

MARIA DEL CARMEN CABEZAS GUERRA

EE197 EFFICACY AND ECONOMIC IMPACT OF METFORMIN PLUS GLIBENCLAMIDE TREATMENT DURING THE COVID-19 PANDEMIC IN ECUADORIAN OUTPATIENTS WITH TYPE II DIABETES MELLITUS

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

Adult T2DM patients treated with MG combination from January to December 2021 were included. Patient chart’s information was collected using a Capture Report Form to evaluate the efficacy and management of these outpatients. Drug and services prices were taken from the National Public Procurement Service, while medical cost estimations were obtained from the National Fare System (2014 and 2019). A Microsoft Excel budget model was developed to calculate the DMC. The study was approved by the Institutional Review Board Ethics Committee

Idioma original	Español (Ecuador)
Publicación	Value in Health
Estado	Publicada - 15 dic. 2022
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Otros archivos y enlaces

https://www.valueinhealthjournal.com/article/S1098-3015(22)02651-1/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301522026511%3Fshowall%3Dtrue

Citar esto

@article{acbebd408a6a4ff2b6bb128f66ef980f,

title = "EE197 EFFICACY AND ECONOMIC IMPACT OF METFORMIN PLUS GLIBENCLAMIDE TREATMENT DURING THE COVID-19 PANDEMIC IN ECUADORIAN OUTPATIENTS WITH TYPE II DIABETES MELLITUS",

abstract = "Adult T2DM patients treated with MG combination from January to December 2021 were included. Patient chart{\textquoteright}s information was collected using a Capture Report Form to evaluate the efficacy and management of these outpatients. Drug and services prices were taken from the National Public Procurement Service, while medical cost estimations were obtained from the National Fare System (2014 and 2019). A Microsoft Excel budget model was developed to calculate the DMC. The study was approved by the Institutional Review Board Ethics Committee",

author = "{CABEZAS GUERRA}, {MARIA DEL CARMEN}",

year = "2022",

month = dec,

day = "15",

language = "Espa{\~n}ol (Ecuador)",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - EE197 EFFICACY AND ECONOMIC IMPACT OF METFORMIN PLUS GLIBENCLAMIDE TREATMENT DURING THE COVID-19 PANDEMIC IN ECUADORIAN OUTPATIENTS WITH TYPE II DIABETES MELLITUS

AU - CABEZAS GUERRA, MARIA DEL CARMEN

PY - 2022/12/15

Y1 - 2022/12/15

N2 - Adult T2DM patients treated with MG combination from January to December 2021 were included. Patient chart’s information was collected using a Capture Report Form to evaluate the efficacy and management of these outpatients. Drug and services prices were taken from the National Public Procurement Service, while medical cost estimations were obtained from the National Fare System (2014 and 2019). A Microsoft Excel budget model was developed to calculate the DMC. The study was approved by the Institutional Review Board Ethics Committee

AB - Adult T2DM patients treated with MG combination from January to December 2021 were included. Patient chart’s information was collected using a Capture Report Form to evaluate the efficacy and management of these outpatients. Drug and services prices were taken from the National Public Procurement Service, while medical cost estimations were obtained from the National Fare System (2014 and 2019). A Microsoft Excel budget model was developed to calculate the DMC. The study was approved by the Institutional Review Board Ethics Committee

UR - https://www.valueinhealthjournal.com/article/S1098-3015(22)02651-1/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301522026511%3Fshowall%3Dtrue

M3 - Artículo

SN - 1098-3015

JO - Value in Health

JF - Value in Health

ER -